Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like Is Celgene Considering Going Private? March 14, 2018 4 Biotechs Facing Do-or-Die Catalysts in December December 5, 2017 Palatin Forges $40.5M+ Deal With Korea's Kwangdong Pharma November 20, 2017
